Shiraz E-Medical Journal

Published by: Kowsar
Crossmark

Nifedipine Versus Magnesium Sulfate for Treatment of Preterm Labor: Comparison of Efficacy and Adverse Effects in a Randomized Controlled Trial

Maryam Khooshideh 1 , Javad Rahmati 2 and Batool Teimoori 3 , *
Authors Information
1 Departement of Obstetrics and Gynecology, Arash Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 Departement of Aesthetic Surgery, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
3 Departement of Obstetrics and Gynecology, Zahedan University of Medical Sciences, Zahedan, Iran
Article information
  • Shiraz E-Medical Journal: June 2017, 18 (6); e46875
  • Published Online: May 7, 2017
  • Article Type: Research Article
  • Received: February 20, 2017
  • Revised: March 18, 2017
  • Accepted: April 22, 2017
  • DOI: 10.5812/semj.46875

To Cite: Khooshideh M, Rahmati J, Teimoori B. Nifedipine Versus Magnesium Sulfate for Treatment of Preterm Labor: Comparison of Efficacy and Adverse Effects in a Randomized Controlled Trial, Shiraz E-Med J. 2017 ; 18(6):e46875. doi: 10.5812/semj.46875.

Abstract
Copyright © 2017, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Flenady V, Wojcieszek AM, Papatsonis DN, Stock OM, Murray L, Jardine LA, et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev. 2014; (6)[DOI][PubMed]
  • 2. Dombrowski MP, Schatz M, Acog Committee on Practice Bulletins-Obstetrics . ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy. Obstet Gynecol. 2008; 111(2 Pt 1): 457-64[DOI][PubMed]
  • 3. Psomiadis N, Goldkrand J. Efficacy of aggressive tocolysis for preterm labor with advanced cervical dilatation. J Matern Fetal Neonatal Med. 2005; 18(1): 47-52[DOI][PubMed]
  • 4. Norwitz ER, Robinson JN, Challis JR. The control of labor. N Engl J Med. 1999; 341(9): 660-6[DOI][PubMed]
  • 5. Lewis DF. Magnesium sulfate: the first-line tocolytic. Obstet Gynecol Clin North Am. 2005; 32(3): 485-500[DOI][PubMed]
  • 6. Wolf HT, Huusom L, Weber T, Piedvache A, Schmidt S, Norman M, et al. Use of magnesium sulfate before 32 weeks of gestation: a European population-based cohort study. BMJ Open. 2017; 7(1): 13952[DOI][PubMed]
  • 7. Crowther CA, Brown J, McKinlay CJ, Middleton P. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev. 2014; (8)[DOI][PubMed]
  • 8. Grimes DA, Nanda K. Magnesium sulfate tocolysis: time to quit. Obstet Gynecol. 2006; 108(4): 986-9[DOI][PubMed]
  • 9. Malaeb SN, Rassi AI, Haddad MC, Seoud MA, Yunis KA. Bone mineralization in newborns whose mothers received magnesium sulphate for tocolysis of premature labour. Pediatr Radiol. 2004; 34(5): 384-6[DOI][PubMed]
  • 10. Gano D, Ho ML, Partridge JC, Glass HC, Xu D, Barkovich AJ, et al. Antenatal Exposure to Magnesium Sulfate Is Associated with Reduced Cerebellar Hemorrhage in Preterm Newborns. J Pediatr. 2016; 178: 68-74[DOI][PubMed]
  • 11. Binette A, Blouin S, Ardilouze A, Pasquier JC. Neuroprotective effects of antenatal magnesium sulfate under inflammatory conditions in a Sprague-Dawley pregnant rat model. J Matern Fetal Neonatal Med. 2016; : 1-6[DOI][PubMed]
  • 12. Zeng X, Xue Y, Tian Q, Sun R, An R. Effects and Safety of Magnesium Sulfate on Neuroprotection: A Meta-analysis Based on PRISMA Guidelines. Medicine (Baltimore). 2016; 95(1): 2451[DOI][PubMed]
  • 13. Haas DM, Caldwell DM, Kirkpatrick P, McIntosh JJ, Welton NJ. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ. 2012; 345: 6226[DOI][PubMed]
  • 14. Practice Bulletin No. 159: Management of Preterm Labor. Obstet Gynecol. 2016; 127(1): 29-38[DOI][PubMed]
  • 15. Glock JL, Morales WJ. Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study. Am J Obstet Gynecol. 1993; 169(4): 960-4[PubMed]
  • 16. Lyell DJ, Pullen K, Campbell L, Ching S, Druzin ML, Chitkara U, et al. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial. Obstet Gynecol. 2007; 110(1): 61-7[DOI][PubMed]
  • 17. Papatsonis DN, Van Geijn HP, Ader HJ, Lange FM, Bleker OP, Dekker GA. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet Gynecol. 1997; 90(2): 230-4[DOI][PubMed]
  • 18. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992; 327(2): 76-81[DOI][PubMed]
  • 19. Cox SM, Sherman ML, Leveno KJ. Randomized investigation of magnesium sulfate for prevention of preterm birth. American J Obstetrics Gynecol. 1990; 163(3): 767-72
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments